• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist


14.8700 USD 0.1300 0.88%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Osiris Therapeutics Inc (OSIR)

Open: 14.7400 Day's Range: 14.7201 - 15.0400 Volume: 47,703
Previous Close: 14.7400 52wk Range: 11.8004 - 18.4100 1-Yr Rtn: -9.44%

Stock Chart for OSIR

No chart data available.
  • OSIR:US 14.8700
  • 1D
  • 1M
  • 1Y
Interactive OSIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OSIR

Current P/E Ratio (ttm) 253.4904
Estimated P/E(12/2014) -
Relative P/E vs. SPX 13.7493
Earnings Per Share (USD) (ttm) 0.0587
Est. EPS (USD) (12/2014) -0.0550
Est. PEG Ratio -
Market Cap (M USD) 510.34
Shares Outstanding (M) 34.32
30 Day Average Volume 94,510
Price/Book (mrq) 6.2149
Price/Sale (ttm) 10.4585
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OSIR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OSIR

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Jonathan M Hopper "Jon"Chief Medical OfficerFrank D Czworka JrVP/General Manager:Wound Care
More Company Profile & Key Executives for OSIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil